LADENBURG THALMANN FINANCIAL SERVICES INC. - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 81 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 6.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2018$6,000
+200.0%
500
+25.0%
0.00%
Q4 2016$2,0000.0%4000.0%0.00%
Q3 2016$2,000
-50.0%
400
-46.1%
0.00%
Q2 2016$4,0000.0%7420.0%0.00%
Q1 2016$4,0000.0%742
+85.5%
0.00%
Q4 2015$4,000
-55.6%
400
-24.7%
0.00%
Q3 2015$9,000
-10.0%
531
+6.2%
0.00%
Q2 2015$10,000
+42.9%
500
+25.0%
0.00%
Q1 2015$7,000
+16.7%
4000.0%0.00%
Q4 2014$6,0004000.00%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q1 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,240,709$23,259,0003.12%
PRINCETON CAPITAL MANAGEMENT INC 34,825$361,0000.25%
Freedom Investment Management, Inc. 118,284$1,228,0000.09%
Spark Investment Management LLC 62,800$651,0000.08%
GSA CAPITAL PARTNERS LLP 98,901$1,027,0000.05%
Baker Brothers Advisors 499,193$5,182,0000.04%
KILLEN GROUP INC 31,000$322,0000.03%
GROUP ONE TRADING, L.P. 127,263$1,321,0000.02%
A.R.T. Advisors, LLC 27,049$280,0000.01%
QS Investors, LLC 132,027$1,370,0000.01%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders